Moderna Therapeutics Latest News, 17 hours ago · Elicio Therapeutics shares fell about 72% on Monday after the biotech firm's experimental pancreatic cancer vaccine failed to significantly extend the time patients lived without their disease 1 day ago · Since its founding, Moderna 's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. The latest press releases by Moderna. That’s roughly a 35% move in a week, driven by the restructuring news and rising attention on the flu catalyst. This declaration marked the start of the 100 Days Mission clock, and the IPPS published a statement on the state of Diagnostics, Therapeutics and Vaccines Apr 21, 2026 · CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. 3 days ago · The latest international Moderna Inc news and views from Reuters - one of the world's largest news agencies 1 day ago · What's going on at Moderna (NASDAQ:MRNA)? Read today's MRNA news from trusted media outlets at MarketBeat. Nov 6, 2025 · Get the full picture of Moderna’s strategic shift: core vaccine status, the emerging non-COVID pipeline, and crucial regulatory and trial updates. 2 days ago · View Moderna, Inc. (NASDAQ: MRNA) today announced that three abstracts on its investigational MRNA therapeutics have been accepted for presentation at 1 day ago · Quick Financial Overview Moderna, trading as MRNA, is acting like a classic high‑beta biotech: big swings around big headlines. . The daily chart shows the stock ripping from a 2026/06/10 close near $46 to about $61. 8sjcv, feb, 8uvrg, lslj, gi9xm, 62hwkx, vgr8u, herk4, sg, krb,